Data analysis of electronic nose technology in lung cancer: generating prediction models by means of Aethena

被引:44
作者
Kort, Sharina [1 ]
Brusse-Keizer, Marjolein [2 ]
Gerritsen, Jan-Willem [3 ]
van der Palen, Job [2 ,4 ]
机构
[1] Med Spectrum Twente, Dept Pulm Med, Enschede, Netherlands
[2] Med Spectrum Twente, Med Sch Twente, Enschede, Netherlands
[3] eNose Co, Zutphen, Netherlands
[4] Univ Twente, Dept Res Methodol Measurement & Data Anal, Enschede, Netherlands
关键词
lung cancer; electronic nose; exhaled breath; aeonose; prediction models; data analysis; VOLATILE ORGANIC-COMPOUNDS; COMPUTED-TOMOGRAPHY; COST-EFFECTIVENESS; BREATH; VALIDATION; MORTALITY; DECISION;
D O I
10.1088/1752-7163/aa6b08
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Introduction. Only 15% of lung cancer cases present with potentially curable disease. Therefore, there is much. interest in a fast, non-invasive tool to detect lung cancer earlier. Exhaled breath analysis using. electronic nose technology measures volatile organic compounds (VOCs) in exhaled breath that. are associated with lung cancer. Methods. The diagnostic accuracy of the Aeonose (TM) is currently being studied in a multi-centre, prospective study in 210 subjects suspected for lung cancer, where approximately half will have a confirmed diagnosis and the other half will have a rejected diagnosis of lung cancer. We will also include 100-150 healthy control subjects. The eNose Company (provider of the Aeonose (TM)) uses a software program, called Aethena, comprising pre-processing, data compression and neural networks to handle big data analyses. Each individual exhaled breath measurement comprises a data matrix with thousands of conductivity values. This is followed by data compression using a Tucker3-like algorithm, resulting in a vector. Subsequently, model selection takes place after entering vectors with different presets in an artificial neural network to train and evaluate the results. Next, a 'judge model' is formed, which is a combination of models for optimizing performance. Finally, two types of cross-validation, being 'leave-10%-out' cross-validation and 'bagging', are used when recalculating the judge models. These judge models are subsequently used to classify new, blind measurements. Discussion. Data analysis in eNose technology is principally based on generating prediction models that. need to be validated internally and externally for eventual use in clinical practice. This paper describes the analysis of big data,. captured by eNose technology in lung cancer. This is done by means of generating prediction models with Aethena, a data analysis program specifically developed for analysing VOC data.
引用
收藏
页数:10
相关论文
共 50 条
[11]   Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises [J].
Boots, Agnes W. ;
Bos, Lieuwe D. ;
van der Schee, Marc P. ;
van Schooten, Frederik-Jan ;
Sterk, Peter J. .
TRENDS IN MOLECULAR MEDICINE, 2015, 21 (10) :633-644
[12]   Enabling a transferable calibration model for metal-oxide type electronic noses [J].
Bruins, Marcel ;
Gerritsen, Jan Willem ;
van de Sande, Wendy W. J. ;
van Belkum, Alex ;
Bos, Albert .
SENSORS AND ACTUATORS B-CHEMICAL, 2013, 188 :1187-1195
[13]   A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis [J].
Chen, Xing ;
Xu, Fengjuan ;
Wang, Yule ;
Pan, Yuefeng ;
Lu, Deji ;
Wang, Ping ;
Ying, Kejing ;
Chen, Enguo ;
Zhang, Weimin .
CANCER, 2007, 110 (04) :835-844
[14]  
Chirikos TN, 2003, JAMA-J AM MED ASSOC, V289, P2358, DOI 10.1001/jama.289.18.2358-a
[15]   An investigation on electronic nose diagnosis of lung cancer [J].
D'Amico, Arnaldo ;
Pennazza, Giorgio ;
Santonico, Marco ;
Martinelli, Eugenio ;
Roscioni, Claudio ;
Galluccio, Giovanni ;
Paolesse, Roberto ;
Di Natale, Corrado .
LUNG CANCER, 2010, 68 (02) :170-176
[16]   An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD [J].
Dragonieri, Silvano ;
Annema, Jouke T. ;
Schot, Robert ;
van der Schee, Marc P. C. ;
Spanevello, Antonio ;
Carratu, Pierluigi ;
Resta, Onofrio ;
Rabe, Klaus F. ;
Sterk, Peter J. .
LUNG CANCER, 2009, 64 (02) :166-170
[17]  
Gates TJ, 2014, AM FAM PHYSICIAN, V90, P625
[18]   The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours [J].
Goldstraw, Peter ;
Crowley, John ;
Chansky, Kari ;
Giroux, Dorothy J. ;
Groome, Patti A. ;
Rami-Porta, Ramon ;
Postmus, Pieter E. ;
Rusch, Valerie ;
Sobin, Leslie .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :706-714
[19]  
GORDON SM, 1985, CLIN CHEM, V31, P1278
[20]   Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification [J].
Hauschild, A. -C. ;
Baumbach, J. I. ;
Baumbach, J. .
GENETICS AND MOLECULAR RESEARCH, 2012, 11 (03) :2733-2744